Blood lead in the 21st Century: The sub-microgram challenge by Amaya, Maria A et al.
© 2010 Amaya et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article  
which permits unrestricted noncommercial use, provided the original work is properly cited.
Journal of Blood Medicine 2010:1 71–78
Journal of Blood Medicine
P E R S P E C T I V E S
open access to scientific and medical research
Open Access Full Text Article
71
Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
7765
Blood lead in the 21st Century:  
The sub-microgram challenge
Maria A Amaya1 
Kevin W Jolly2 
Nicholas E Pingitore Jr1,3
1School of Nursing, The University  
of Texas at El Paso, El Paso, TX, USA; 
2Department of Psychology,  
The University of Texas at El Paso,  
El Paso, Texas, USA; 3Department of 
Geological Sciences, The University of 
Texas at El Paso, El Paso, TX, USA
Correspondence: Maria A Amaya 
School of Nursing, The University of  
Texas at El Paso,1100 North Stanton 
Street, Suite 410, El Paso, Texas 79902, 
USA 
Tel +1 915-747-8583 
Fax +1 915-747-8279 
Email mamaya@utep.edu
Abstract: In the US the dominant sources of lead through much of the 20th Century (eg, vehicular 
emissions, plumbing, household paint) have been significantly diminished. The reductions in 
adult and pediatric average blood lead levels in the US have been extraordinary. Progress con-
tinues: the US Environmental Protection Agency recently developed a new air standard for lead. 
In the 21st Century, the average blood lead level in a society may be seen as a marker of the 
status of their public’s health. However, the threat of lead exposure remains a significant public 
health problem among subpopulation groups in the US and in many less developed countries. 
This paper examines some of the specific issues involved in the reduction of blood lead in a 
post-industrial era. These involve the control of the remaining exogenous primary sources, both 
general (eg, industrial emissions) and specific (eg, at-risk occupations), exogenous secondary 
sources (eg, contaminated urban soils, legacy lead-based paints), an endogenous source (ie, 
cumulative body lead burden) and emergent sources.
Keywords: environmental contaminants, public health, environmental policy, blood lead
Introduction
The average level of lead (Pb) in blood may be seen by society as evidence of its 
commitment to its own health. Thus the concentration of a particular metal in our 
collective blood informs the condition of our society.
We present in Table 1 a chronology of the progression of human blood lead level 
(BLL) through time. Different societies have entered the stages at different points in 
time. The traditional industrial powerhouses (eg, the US, Europe, Japan) are in late Stage 
3 and early Stage 4. Such emerging economies as China appear to be in Stages 2 and 3. 
Even within a society, some lead-related activities may not be indicative of a society’s 
Stage. Likewise the BLL of sectors of a society, because of socioeconomic status or 
racial issues, may reflect a different Stage than that of the society as a whole.
In this paper, we examine some of the specific issues involved in the transition from 
a late industrial to a post-industrial society in the US. These issues include exogenous 
primary sources, both general (eg, fuel burning) and specific (eg, at-risk occupations); 
exogenous secondary sources (eg, contaminated urban soils, legacy lead-based paints), 
an endogenous source, or the bone-lead burden remaining from Stage 3, and emergent 
sources related to global trade and pollution from Stage 2 societies.
Hematologic considerations
The major hematologic effect of lead is iron-deficient microcytic, hypochromic ane-
mia. Anemia is among the most common signs of lead toxicity observed in children. Journal of Blood Medicine 2010:1 72
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Lead inhibits the production of porphobilinogen synthase by 
the precursor δ-aminolevulinic acid dehydratase (ALAD). 
The ALAD enzyme is a zinc-dependent protein that catalyzes 
heme synthesis to form monopyrrole porphobilinogen, a 
precursor of heme. The heme synthesis process ends with 
the insertion of positively charged iron (Fe2+) into negatively 
charged protoporphyrin. Lead interferes with the binding of 
iron and protoporhyrin, resulting in high circulating levels 
of zinc protoporhyrin (ZPP). Studies have focused on the 
bio-kinetics of lead and ALAD gene expression in an effort 
to identify genetic biomarkers of risk among children.
The ALAD gene is located in chromosome 9q34. Eight 
human ALAD gene variants have been described. One 
polymorphism yields two alleles, designated ALAD-1 and 
ALAD-2. ALAD-1 homozygotes produce the least elec-
tronegative enzyme; ALAD 1–2 heterozygotes produce an 
intermediate electronegative enzyme; ALAD-2 heterozygotes 
produce the most electronegative enzyme. This means that 
ALAD-2 proteins bind to positively charged lead ions more 
tightly than ALAD-1 homozygotes and heterozygotes.
Originally, it was hypothesized that carriers of the 
ALAD-2 allele who are exposed to lead carry that lead in 
the blood longer, and therefore are more likely to express 
acute manifestation after exposure.7 However, others 
found that the mechanisms by which ALAD genotype 
may modify the compartmentalization and movement of 
lead are more complex.8–11 Polymorphisms of the vitamin 
D receptor (VDR) gene have been studied for their con-
tribution to the kinetics of lead.10 VDR polymorphisms 
determine calcitriol hormone expression and bone mineral 
density (BMD). Dietary calcium and iron intake, alcohol 
use and smoking also affect BMD. Iron and calcium defi-
ciencies are both associated with higher uptake of lead 
ions, especially in children. Ferritin, the iron transport 
protein, binds as well to lead as it does to calcium. Children 
that are already iron-deficient and calcium-deficient have 
increased circulating ferritin proteins that can bind more 
lead ions. In addition, patients with hemochromatosis (a 
disease of iron overload) have been shown to have higher 
circulating lead levels.
Health effects of lead exposure
Children
Lead exposure is implicated in a broad clinical spectrum 
of disease, including hematological, renal, cardiovascular, 
  neurological, developmental, and behavioral disorders. 
By the end of the 20th Century a strong body of scientific 
evidence showed that children’s ability to learn, memorize, 
behave normally, and concentrate was adversely affected by 
chronic low-level lead exposure, or BLL 10 µg/dL.12–19 
  Neurotoxic lead effects are particularly deleterious to 
  developing central nervous systems in children.19–21 CNS 
damage during the perinatal period from maternal lead body 
burden is also well documented.20 Covariants such as pheno-
type,7–11 nutritional status, and social, economic, and cultural 
factors may alleviate or exacerbate these effects.13,22–24
The Centers for Disease Control and Prevention (CDC) 
still defines the blood lead intervention threshold in children to 
be 10 µg/dL.25,26 However, a 2007 report by the Agency for 
Toxic Substances and Disease Registry27 summarized the large 
body of more recent evidence for adverse health effects at lower 
BLL thresholds. Even BLL as high as 5 µg/dL may adversely 
affect a child’s cognitive development28–31 and physical 
maturation.32 The risk of adverse effects from lead exposure 
is also higher amongst population subgroups, including 
ethnic minorities, low-income groups and those clustered in 
geographic lead pools. Bernard and McGeehin’s33 analysis 
of data collected as part of the Third National Health and 
Table 1 Stages in the succession of societal blood lead level
Stage condition Time frame Typical BLL Health effects
Stage 1 Primitive to ∼500 BCE 1 µg/dL?, world none
Low population. Extraction of metals from ores on a small scale late in this stage
Stage 2 Industrial 500 BCE–1970s 10 µg/dL, US. acute and chronic
Extraction of silver from galena (PbS) by Greeks and Romans marks first large-scale release of Pb to the environment. Increasing releases from 
  industrial revolution (1750 onward), culminating in 20th Century with leaded gasoline and lead-based paints.
Stage 3 Late-Industrial 1970s–2000 1–5 µg/dL, US. developmental
Clean Air Act, phase-out of leaded gasoline, actions on lead-based paint, pipes, and solder. Dramatic drop in US BLL.
Stage 4 Post-Industrial 2000– 1 µg/dL possible goal none?
Remediation or sequestration of secondary sources in soil, old building paints, plumbing. Increased control over remaining primary sources, eg, piston 
aviation fuel, incineration, and coal and gasoline combustion, and substitution for Pb in industrial products, eg, batteries, plasticizers.
Notes: Data from: Settle and Patterson1; National Research Council2; Davidson and Rabinowitz3; Needleman4; Warren5; Reuer and Weiss.6Journal of Blood Medicine 2010:1 73
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Nutrition Examination Survey (NHANES-III) revealed that 
23% and 15% of Mexican-American and non-Hispanic white 
children, respectively, displayed blood lead levels between 
5 and 10 µg/dL. Nearly one-third (32%) of non-Hispanic black 
children had blood lead levels within that range.
Adults
The CDC threshold for intervention in adults is a blood lead 
level 25 µg/dL. The vast majority of cases are related to 
  occupational exposure.34 A growing body of evidence now links 
lifetime cumulative lead exposure, as well as current exposure, 
to chronic health disorders seen in older adults. A systematic 
review by Navas-Acien et al found that hypertension is one 
of the most consistent cardiovascular outcomes seen among 
lead-exposed subjects. There is an estimated increase of 0.6 to 
1.25 mmHg associated with every two fold increase in blood 
lead levels (ie, from 5 to 10 µg/dL). Experimental, mechanistic 
and prospective studies support this relationship. The associa-
tions with cardiovascular and coronary heart disease, peripheral 
artery disease and stroke are less clear.35
Tsaih et al reported on the relationship between lead, 
diabetes, hypertension and renal function in 448 subjects 
that had been selected from the Normative Aging Study 
(NAS), and in which bone and blood lead were measured at 
baseline and follow-up. Age, basal metabolic index, alcohol 
consumption, smoking status, diabetes, hypertension and 
baseline serum creatinine were measured. Bone lead level 
predicted diabetes, hypertension, and progression of kidney 
disease. The association between bone lead (particularly tibial 
bone lead) and renal disease was stronger among diabetic 
subjects.36
Unlike the direct causal relationship between acute lead 
exposure (up to 70–80 µg/dL) and nephrotoxicity, the rela-
tionship between low-level chronic exposure and renal out-
comes from cumulative stores has been less well understood. 
Recent epidemiologic evidence supports relationships 
between lead exposure and renal dysfunction in adults.37,38 
Peters et al studied hypertension status in 513 participants 
recruited from the NAS. They found a positive interaction 
between stress and bone lead on systolic blood pressure, after 
adjusting for age, body mass index, family history of high 
blood pressure, education, smoking, alcohol consumption, 
physical activity and nutritional factors.39
Sources of lead exposure: Banned 
but not gone
Lead is a soft, malleable metal that has proven both 
  magnificent and devastating to human societies through 
the ages. The oldest lead artifact dates from approximately 
3000 BCE. Although lead is a naturally occurring heavy 
metal (at levels of approximately 15–20 µg/g in Earth’s crust 
and uncontaminated soils), the roots of human exposures 
are almost exclusively man-made. Use of lead in ancient 
  civilizations is well documented, as is lead exposure in 
archeological finds of human remains. The element lead itself 
is, of course, essentially indestructible; its compounds are 
variably toxic, bioavailable, and biodegradable. Humans can 
absorb lead through the gastrointestinal tract, by inhalation, 
or, for certain compounds, by absorption through the skin.
A reasonable benchmark for the wealthy societies in 
Europe, the US and elsewhere might be to achieve a typical 
BLL of  1 µg/dL in their populations. The Healthy People 
2010 national public health objectives, to reduce to zero the 
prevalence of elevated BLL in children (BLL 10 µg/dL) and 
in adults (BLL  25 µg/dL), fall well short of the unspoiled 
historic benchmark. This demonstrates continued societal 
tolerance for low-level chronic lead exposure. A recent meta-
analysis of children’s IQ scores and their blood lead concen-
trations showed that each incremental 1 µg/dL increase in 
blood lead concentration resulted in a one-point decrease in 
IQ score (in school-aged children).30 One research team has 
called for lowering the blood lead action level in children 
from 10 to 2 µg/dL.40
In the late industrial Stage 3, US regulatory statutes and 
public awareness have had great impact in reducing adult and 
childhood blood lead levels. However, by post industrial Stage 
4 it is critical to address the heritage of accumulated lead. It 
is important to understand the changing face of exposure and 
risk by tracing the current pathways by which lead reservoirs 
are maintained and recycled.
Exogenous primary sources of lead
The major primary contemporary sources of lead emission in 
the US include leaded aviation fuel for piston-driven engines, 
manufacturing, and metal operations. The emission route 
of greatest concern is through the air, which is naturally 
  dispersive, pervasive, and, unlike an oil spill, impossible to 
remediate. The new US Environmental Protection Agency air-
borne lead standard of 0.15 µg/m3 represents a 90% decrease 
from the 1978 standard of 1.5 µg/m3.41 From a public health 
perspective, although no level of lead exposure is considered 
absolutely safe, primary airborne lead emissions no longer 
represent the major challenge in decreasing BLLs.
Despite this significant decrease in airborne lead 
  levels, workers in the primary lead-impacted industries or 
  activities (eg, recycling) remain at risk from lead exposure. Journal of Blood Medicine 2010:1 74
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The families of such workers also may be at risk from 
lead transferred to the home or automobile from the work-
place. Even as the US enters Stage 4, many of the workers 
  responsible for this transition remain occupationally at-risk 
of lead exposure. Sources of occupational lead exposure 
include the mining and smelting industries, refineries, 
  construction and remodeling, auto mechanics, plumbing, 
soldering and pottery-making. Occupationally acquired lead 
may be transported to the household setting in work clothes 
and shoes. Particulate emissions from industries, such as 
local smelters or demolition, remain as sources of human 
lead exposure.42–45
Other primary sources in Stage 3 include lead plumbing 
pipes and solder; lead-based paints; lead solder in the 
food industry (eg, cans); and lead in a variety of consumer 
  products, such as cosmetics, pharmaceuticals, crayons, inks, 
etc. Most of these sources are closely regulated, or eliminated 
by industry consent. Nonetheless, legacy issues remain (paint, 
plumbing) to produce secondary sources, and misuse of lead 
in consumer products re-emerges with global trade.
Of special pediatric interest are such lead-containing 
products as glazed pottery,46 imported candy,47 and culture–
bound traditional remedies for illness.48 Lead used in products 
targeting children, including candy and toys, pose particular 
threats to children’s health. Despite a 2007 joint agreement 
between the US Consumer Product Safety Commission 
and China’s consumer regulatory agency to ban lead paint 
on products destined for the US, products tainted with lead 
continue to pose a health hazard for children worldwide.
Exogenous secondary sources of lead
The major pervasive 20th Century sources of environmental 
lead in the US were leaded gasoline, lead-based paint and lead 
plumbing materials. These materials remain as secondary 
sources, and their removal or sequestration are a major target 
of societies intent on reaching Stage 4.
Lead-based paint
Lead-based house paint was widely used in the US in the 
first half of the 20th Century. Basic lead carbonate (“Dutch 
process”) and other lead salts were present at levels of “tens of 
percent”.49,50 With growing concerns about children’s health 
in the 1970’s,51,52 lead was finally banned from household 
paint in the US.53,54 The Residential Lead-Based Paint Hazard 
Reduction Act of 1992,55 also known as Title X, was enacted 
to protect families from exposure to lead from paint, dust, 
and soil, in recognition of the need for strategies to address 
the legacy of lead-based paint in older homes. Section 1018 
of this law directed the US Department of Housing and 
Urban Development (HUD) and the US Environmental 
Protection Agency (EPA) to require the disclosure of known 
information on lead-based paint and lead-based paint hazards 
before the sale or lease of most housing built before 1978. 
A 1998–2000 national survey estimated that about 38 million 
homes contain lead-based paint.56 Lead particles readily settle 
in household dust and can be a toxic source.57,58
Residual lead-based paint presents numerous challenges 
in Stage 4. Older urban housing with lead-based paint 
  typically faces one of several fates. Degradation occurs 
when the house or neighborhood value relegates the 
building to a substandard, low-rent condition. Under such 
  circumstances, lead-based paint will be mobilized due to lack 
of upkeep, ie, sequestration by painting over. Renovation 
can lead to mobilization unless proper care is taken during 
the project. Demolition typically leads to mobilization and 
  dispersal. Paint removal/remediation is expensive, and, if 
not performed by professionals, also dispersive.
Lead in urban soil
The addition of tetra-ethyl lead to gasoline as an anti-knock 
agent began in the 1920’s and resulted in massive roadside 
and airborne emission of a variety of reactive lead-halogen 
compounds. These dispersed into and reacted with urban soils. 
Lead additives in gasoline were gradually phased out in the US 
over a 24-year period ending in 1996.59 The first EPA reduc-
tion standard was published in 1973.53 By 1975 most cars and 
light trucks were manufactured with catalytic converters that 
required lead-free fuel. Lead-containing fuel continues to be 
sold for piston aircraft, and classic and racing cars.
Our group used synchrotron-based X-ray absorption 
fine structure (XAFS) to identify and quantify the major Pb 
species in numerous soils and air samples in El Paso, TX.60 
Lead humate, and perhaps some similar sorbed forms of lead, 
is the dominant form of lead in contemporary El Paso soil 
and air. Lead humate is a stable, sorbed complex produced 
exclusively in the humus fraction of Pb-contaminated soils. 
Legacy lead from automobile exhaust, lead-based paint, and 
industry have reacted over time to yield lead-humate. This 
material is re-suspended into the local air, and enters houses 
where it may be available for accidental ingestion by tod-
dlers. We found that the form of lead present in household 
dust wipes was similar to that found in soil lead, with some 
contribution from lead paint.61,62
Although humates are biologically active, the relative 
bioavailability of lead sorbed on soil is thought to be lower 
compared to other forms of lead. Casteel et al found that Journal of Blood Medicine 2010:1 75
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the bioavailability of lead in soil and soil-like materials 
varied between 6% and 105%. Although soil chemistry is 
important in determination of bioavailability, speciation 
data are not yet adequate to predict bioavailability of lead 
in soil.63
Lead plumbing
Lead contamination of water distribution systems includes 
lead pipes, lead solder on copper pipes, and plumbing 
  fixtures.64 Legislation has eliminated the installation of 
such pipes and solder; brass fixtures containing lead are no 
  longer used in kitchens. Nonetheless, many such installations 
remain in service and drinking water is still a potential or 
actual source of ingested lead. Scaling formed on the inner 
surfaces of lead pipes and solder often prevents leaching of 
lead, a phenomenon similar to the painting over of lead-based 
paints. But the pH and chemistry of the water can result in 
lead leaching at unhealthy levels.
The removal of lead from municipal water distribution 
systems, the upgrading of plumbing in older houses, and 
the inexorable attrition of older housing through demolition 
are gradually decreasing the actual and potential transfer of 
lead to drinking water. Hastening this process should be a 
component of a society’s Stage 4 lead strategy.
Endogenous lead source – body  
lead burden
Lead exposure in industrialized countries such as the US 
tends toward low-dose, temporal or chronic exposure. 
Although technologies for measuring body lead burden have 
improved, technologies for discerning health effects have 
not advanced as much. Blood is a short-term reservoir for 
body lead burden. Blood lead measurement is the standard 
for pediatric and adult clinical surveillance,65 although 
twenty-four-hour urine analyses provide useful clinical 
measures of heavy metals (eg, lead, cadmium), renal function 
(creatinine) and bone resorption (eg, calciuria, calciotropic 
hormones).66–68
Lead that is deposited in bone remains sequestered 
for considerably longer periods of time relative to lead 
found in the blood or soft tissue.69 The cumulative dose of 
lead absorbed throughout the lifecycle in adults is reliably 
  measured by K-shell X-ray fluorescence (KXRF) of the 
bone.70,71 Lead that is stored in porous trabecular bone is 
thought to be more bio-available and may have a shorter 
half-life compared to dense cortical bone.37 The prolonged 
half-life of lead in bone makes it a useful benchmark of 
chronic lead exposure that may not manifest in BLL.72
Cadmium-source KXRF is used to estimate cumulative lead 
exposure using both patellar and tibial bone.71 Lead sequestered 
in the bone is measured as µg/g of mineralized bone. KXRF 
can provide a relatively unbiased estimate of bone lead levels, 
normalized to bone mineral content as micrograms of lead per 
gram of bone mineral.38,73–77 The half-life of lead sequestered 
in bone can extend to 15 years. About 95% of the lead in the 
body of an adult, and up to 70% of the lead in the body of a 
child, is thought to be sequestered in the bones.78–80
Limitations of the KXRF technique are related to detection 
limits for lead and interpretation of results.70 Lead levels 
  measured by KXRF vary according to BMD. In turn, BMD 
may vary by age, ethnicity and other covariates. Changes 
in BMD occur throughout the lifespan in both men and 
women, such as in pregnancy, lactation or osteoporosis.77,81–83 
  Progress has been made using age-adjusted mean bone 
  mineral curves for areal and volumetric BMD for calculating 
standards among certain ethnic groups.84
The association between body lead burden and social 
adjustment was first investigated using KXRF spectroscopy 
by following through adolescence 301 first grade boys, 
  identified as being at risk for antisocial behavior. The boys 
with higher bone lead levels had a higher risk for attention 
impairment, delinquent behavior and academic failure.22,24 
Others have since found associations between bone lead level 
and low-income, minority status and immigrant status.85,86
Bone lead measurements are more predictive of renal 
function in older subjects, and in subjects with hypertension. 
Wu et al found an association between patellar (trabecular) 
bone lead and renal function in a sample recruited from the 
Normative Aging Study, but no association with ALAD 
genotype.87 In their study of men also recruited from the 
Normative Aging Study, Kim et al found that bone lead is 
associated with age, but lead level remains more consistent 
in tibial bone than in patellar bone or in blood.74
Emergent sources of lead
Because much of the world remains in Stages 2 and 3, the 
movement of people and products into the US and other Stage 
4 nations will present continuing challenges throughout the 
21st Century. Despite regulations, products with unacceptable 
levels of lead (eg, toys from China, candies and lead-glazed 
ceramics from Mexico) can be expected to arrive within 
the US though international trade. Even strong legislation, 
(eg, the European Restriction of Hazardous Substances 
(RoHS) Directive), cannot prevent sporadic importation 
of lead-tainted products. Similarly, immigrants from Stage 
2 or 3 nations may unknowingly carry a locally acquired Journal of Blood Medicine 2010:1 76
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endogenous bone lead burden that will be a potential source 
of blood lead for decades into the future.
Emergent sources can and will also appear from within a 
Stage 3 or 4 nation. For example, in the Washington D.C. area, 
changes in the chemical procedures for treating municipal water 
unexpectedly resulted in leaching of lead from old plumbing 
pipes.88 This presented a serious health challenge to affected 
residents. Undoubtedly, other unanticipated lead “events” will 
mar the attainment of the sub-microgram Stage 4 goal.
Discussion and conclusions
A roadmap to sub-microgram blood lead levels delineates 
the challenges our society will face to meet this goal in the 
21st Century. Regulation of exogenous primary sources of 
lead is straightforward and effective. Control before release 
into the environment can be planned and is usually cost-
  effective. Control of exogenous secondary sources is more 
difficult due to dispersal of the targets. Lead in plumbing 
systems is widespread but not diffuse (the offending materials 
can be mechanically removed) and remediation by replace-
ment is not a particularly hazardous process. Lead-based 
paints are widespread and diffuse, and removal is both 
difficult and hazardous. Abatement by proper maintenance 
is the cost-effective strategy, accompanied by proper regu-
lation of demolition practices. Lead in soil is widespread 
and extremely diffuse. Removal and sequestration of lead-
contaminated soils in hazardous waste dumps is a simple 
mechanical process requiring appropriate safety precautions. 
But the magnitude of this task and the expense involved is 
large. Perhaps a geometric analogy highlights the control 
of secondary sources. Lead plumbing can be thought of as 
a one-dimensional (linear) system composed of pure lead. 
Rip it out. Lead-based paint is a two-dimensional (planar) 
system with high lead content. Paint it over. Contaminated 
soil is a three-dimensional (volumetric) system of diffuse 
lead, at a level less than one percent. Shovel it.
The exogenous body lead burden, a legacy of 20th 
  Century exposures, will persist well into the 21st Century in 
the US and most other countries. It will diminish by natural 
attrition; at present there is no bone-lead cleansing regimen. 
Research methodologies that discern health effects are 
  limited to epidemiologic and genomic designs, and still rely 
much on animal models. The technology for tracking lead 
body burden is reliable for measuring both circulating lead 
and bone-sequestered lead, although KXRF is not clinically 
in use. It is important to consider that many of the covariants 
of lead exposure may also be seen as markers of the overall 
living conditions in a society.
Elimination of lead intake from exogenous sources 
is crucial in controlling future body lead burdens in our 
population. Primary prevention would appear to be the 
most important public policy strategy. Rapid and effective 
response to emerging lead sources is another essential part 
of the strategy to meet the one-microgram goal. Even if the 
one-microgram goal is possible technically, it remains to be 
seen whether it will it be possible politically.
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